Use of tranexamic acid in dogs with primary immune thrombocytopenia: A feasibility study

Use of tranexamic acid in dogs with primary immune thrombocytopenia: A feasibility study

ObjectiveThe aim of this feasibility study is to evaluate the use of tranexamic acid and its safe use alongside standard therapy in dogs with primary immune thrombocytopenia (ITP).DesignThis is a cohort feasibility study involving 10 dogs diagnosed with primary ITP that received standard therapy for...

Full description

Bibliographic Details
Main Authors:	Gerard Olivares, Mellora Sharman, Rachel Miller, Caroline Kisielewicz, Mayank Seth
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Veterinary Science
Subjects:	tranexamic acid canine bleeding score immune thrombocytopenia (ITP) antifibrinolytics
Online Access:	https://www.frontiersin.org/articles/10.3389/fvets.2023.946127/full

Similar Items

A comparison of high-dose and low-dose tranexamic acid antifibrinolytic protocols for primary coronary artery bypass surgery
by: Stephen M McHugh, et al.
Published: (2016-01-01)

Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis
by: Dorela Lame, et al.
Published: (2024-03-01)

Tranexamic Acid in Trauma Management: A Review of Evidence
by: Namryeol Kim
Published: (2023-11-01)

Postoperative Low-Dose Tranexamic Acid After Major Spine Surgery: A Matched Cohort Analysis
by: Lauren K. Dunn, et al.
Published: (2020-12-01)

Tranexamic acid evidence and controversies: An illustrated review
by: Nicole Relke, et al.
Published: (2021-07-01)

Effect of Local Tranexamic Acid on the Quality of Bone Healing in a Rat Spinal Fusion Model
by: Ertugrul Sahin, et al.
Published: (2022-03-01)

Causes of thrombocytopenia in dogs in the United Kingdom: A retrospective study of 762 cases
by: Marina Martín‐Ambrosio Francés, et al.
Published: (2023-07-01)

The effect of ε‐aminocaproic acid on blood product requirement, outcome and thromboelastography parameters in severely thrombocytopenic dogs
by: Johanna Wolf, et al.
Published: (2024-03-01)

Clinical use of tranexamic acid: evidences and controversies
by: Maria J. Colomina, et al.
Published: (2022-11-01)

Efficacy of phytotherapy as nutritional supplements in patients with refractory immune thrombocytopenia
by: Hau D. Tran, et al.
Published: (2023-02-01)

The incidence and clinical burden of immune thrombocytopenia in pediatric patients in the United States
by: Jaime Shaw, et al.
Published: (2020-04-01)

Salts of S-(+)-Ibuprofen Formed via Its Reaction with the Antifibrinolytic Agents Aminocaproic Acid and Tranexamic Acid: Synthesis and Characterization
by: Hannah M. Frösler, et al.
Published: (2023-08-01)

Effect of tranexamic acid on blood loss and transfusion requirement in total knee replacement in the Indian population: A case series
by: Parshotam Lal Gautam, et al.
Published: (2011-01-01)

Partial splenic embolization for refractory thrombocytopenia
by: Irwin M. Best
Published: (2011-12-01)

Tranexamic acid by the intramuscular or intravenous route for the prevention of postpartum haemorrhage in women at increased risk: a randomised placebo-controlled trial (I’M WOMAN)
by: Amy Brenner, et al.
Published: (2023-12-01)

Comparative study of topical vs. intravenous tranexamic acid regarding blood loss in total knee arthroplasty
by: Ari Zekcer, et al.

Editorial: Immune thrombocytopenia (ITP)—diagnosis and treatment
by: Tomás José González-López
Published: (2024-03-01)

Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: Statistical analysis plan for the WOMAN-2 trial: an international, randomised, placebo-controlled trial [version 2; peer review: 2 approved]
by: Ian Roberts, et al.
Published: (2023-08-01)

Efficacy and safety of two rituximab biosimilars for treating immune thrombocytopenia: a reference-product matched study
by: Arthur Mageau, et al.
Published: (2023-12-01)

Tranexamic Acid Use in Pediatric Craniotomies at a Large Tertiary Care Pediatric Hospital: A Five Year Retrospective Study
by: Jue T. Wang, et al.
Published: (2023-06-01)

Thrombocytopenia induced by clopidogrel: a rare adverse effect
by: Catarina Távora, et al.
Published: (2023-10-01)

Response to rituximab in children and adults with immune thrombocytopenia (ITP)
by: Emily M. Harris, et al.
Published: (2021-08-01)

Mechanism of increased efficacy of recombinant Fc‐μTP‐L309C compared to IVIg to ameliorate mouse immune thrombocytopenia
by: Bonnie J.B. Lewis, et al.
Published: (2021-11-01)

Immune Thrombocytopenia (ITP): Current Limitations in Patient Management
by: Deirdra R. Terrell, et al.
Published: (2020-11-01)

Efficacy of Tranexamic Acid Mesotherapy Using a Novel Device versus Topical Tranexamic Acid in Patients with Melasma: Protocol for a Randomised Clinical Trial
by: Yash Kashikar, et al.
Published: (2024-02-01)

Treatment of patients with refractory immune thrombocytopenia: literature review and case report
by: V. V. Ptushkin, et al.
Published: (2014-07-01)

Treatment of patients with refractory immune thrombocytopenia: literature review and case report
by: V. V. Ptushkin, et al.
Published: (2014-07-01)

Plasmin, Immunity, and Surgical Site Infection
by: Stuart Hastings, et al.
Published: (2021-05-01)

ORAL MANIFESTATIONS OF IMMUNE THROMBOCYTOPENIA IN CHILDREN
by: Vasile Eduard Roşu, et al.
Published: (2022-06-01)

Predictors of Remission in Severe Childhood Immune Thrombocytopenia
by: Chao-Neng Cheng, et al.
Published: (2023-01-01)

Low serum vitamin D levels in Iranians with immune thrombocytopenia: A single-center study
by: Mahsa Matinkia, et al.
Published: (2021-11-01)

Lifting the fog over ITP
by: Philip Young-Ill Choi
Published: (2020-04-01)

Pediatric immune thrombocytopenia: a focus on eltrombopag as second-line therapy
by: Giuseppe Palumbo, et al.
Published: (2023-12-01)

IVIG Treatment Response and Age are Important for the Prognosis of Pediatric Immune Thrombocytopenia
by: Min Gi Sakong, et al.
Published: (2022-10-01)

Guidelines of Russian Expert Council on diagnostic and therapy of patients with primary immunne thrombocytopenia
by: A. A. Maschan, et al.
Published: (2022-11-01)

Enhanced Antifibrinolytic Efficacy of a Plasmin-Specific Kunitz-Inhibitor (60-Residue Y11T/L17R with C-Terminal IEK) of Human Tissue Factor Pathway Inhibitor Type-2 Domain1
by: Kanagasabai Vadivel, et al.
Published: (2020-11-01)

Comparison of the effects of Tranexamic Acid and Remifentanil on the Reduction of Intraoperative and Postoperative Hemorrhage during Dacriocystorhynostomy
by: Kamran Montazeri, et al.
Published: (2022-12-01)

Immune thrombocytopenia in 2 healthy young women after the Pfizer‐BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination
by: Emilie C. Collins, et al.
Published: (2021-10-01)

Dentoalveolar Procedures in Immune Thrombocytopenia; Systematic Review and an Institutional Guideline
by: Wobke E. M. van Dijk, et al.
Published: (2021-10-01)

The effect of Tranexamic acid on cardiac surgery bleeding
by: Mohammad Esmaeelzadeh, et al.
Published: (2014-02-01)